Therapeutic relevance of eosinophilic inflammation and airway viral interactions in severe asthma
Allergy · 2024
DOI: 10.1111/all.16242 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Allergy, 2024. Verfasst von Hitasha Rupani und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, University Hospital Southampton NHS Foundation Trust, Southampton, Hampshire, UK. Hauptthemen laut MEDLINE: Asthma, Eosinophils, Inflammation. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 174 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
The role of eosinophils in airway inflammation and asthma pathogenesis is well established, with raised eosinophil counts in blood and sputum associated with increased disease severity and risk of asthma exacerbation. Conversely, there is also preliminary evidence suggesting antiviral properties of eosinophils in the airways. These dual roles for eosinophils are particularly pertinent as respiratory virus infections contribute to asthma exacerbations. Biologic therapies targeting key molecules implicated in eosinophil‐associated pathologies have been approved in patients with severe asthma and, therefore, the effects of depleting eosinophils in a clinical setting are of considerable interest. This review discusses the pathological and antiviral roles of eosinophils in asthma and exacerbations. We also highlight the significant reduction in asthma exacerbations seen with biologic therapies, even at the height of the respiratory virus season. Furthermore, we discuss the implications of these findings in relation to the role of eosinophils in inflammation and antiviral responses to respiratory virus infection in asthma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Respiratory Medicine, University Hospital Southampton NHS Foundation Trust, Southampton, Hampshire, UK.
- Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, Hampshire, UK.
- Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
- Global Medical, Global Specialty and Primary Care, GSK, Brentford, Middlesex, UK.
- Monash Lung Sleep Allergy and Immunology, Monash University and Medical Centre and Hudson Institute, Melbourne, Victoria, Australia.
- Airway Disease Section, National Heart and Lung Institute, Imperial College London, London, UK.
ORCID-Profile: Hitasha Rupani, William W Busse, Peter H Howarth, Philip G Bardin, Ian M Adcock, Satoshi Konno, David J Jackson
Zitieren
APA
Rupani, H., Busse, W. W., Howarth, P. H., Bardin, P. G., Adcock, I. M., Konno, S., & Jackson, D. J. (2024). Therapeutic relevance of eosinophilic inflammation and airway viral interactions in severe asthma. Allergy. https://doi.org/10.1111/all.16242
Vancouver
Rupani H, Busse WW, Howarth PH, Bardin PG, Adcock IM, Konno S, et al. Therapeutic relevance of eosinophilic inflammation and airway viral interactions in severe asthma. Allergy. 2024. doi:10.1111/all.16242
BibTeX
@article{Rupani2024,
author = {Rupani, Hitasha and Busse, William W and Howarth, Peter H and Bardin, Philip G and Adcock, Ian M and Konno, Satoshi and Jackson, David J},
title = {Therapeutic relevance of eosinophilic inflammation and airway viral interactions in severe asthma},
journal = {Allergy},
year = {2024},
doi = {10.1111/all.16242}
}
EUVIMED